reveromycin a has been researched along with clodronic acid in 1 studies
| Studies (reveromycin a) | Trials (reveromycin a) | Recent Studies (post-2010) (reveromycin a) | Studies (clodronic acid) | Trials (clodronic acid) | Recent Studies (post-2010) (clodronic acid) |
|---|---|---|---|---|---|
| 43 | 0 | 19 | 1,748 | 210 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fotovati, A; Hiraoka, K; Hosoi, F; Iguchi, H; Kimura, YN; Kuwano, M; Nagata, K; Ono, M; Osada, H; Shoda, T; Watari, K; Zenmyo, M | 1 |
1 other study(ies) available for reveromycin a and clodronic acid
| Article | Year |
|---|---|
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Disease Models, Animal; Female; Humans; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Monocytes; Muscle Neoplasms; Neoplasm Invasiveness; Pyrans; Spiro Compounds | 2008 |